NautaDutilh and Goodwin Procter LLP advised Xenikos on the deal. Xenikos B.V., a clinical-stage biopharmaceutical company currently developing a novel therapy for treating immune related disorders,...
Xenikos’ €40 Million Convertible Debt Financing
Keensight Capital’s Majority Investment in Symeres
NautaDutilh advised Keensight Capital on the deal. Loyens & Loeff advised Gilde Healthcare’s Private Equity. Keensight Capital completed its second direct investment in the Netherlands, being...